Samrat Pharmachem Limited has announced its unaudited standalone financial results for the quarter and half-year ended September 30, 2026. The company reported a profit of ₹44.11 lakh for the second quarter of the fiscal year 2027. The results were reviewed by the Audit Committee and taken on record by the Board of Directors on November 14, 2026.
Samrat Pharmachem Announces Q2 FY27 Financial Results
Samrat Pharmachem Limited has disclosed its unaudited standalone financial results for the quarter and half-year ended September 30, 2026. The announcement was made on November 14, 2026, following a Board of Directors meeting.
Financial Highlights (Quarter Ended September 30, 2026)
Income Statement
For the quarter ended September 30, 2026, Samrat Pharmachem reported total income of ₹6,617.35 lakh. Total expenses for the same period amounted to ₹6,613.01 lakh.
Profitability
The company recorded a profit before tax of ₹4.34 lakh. After accounting for a tax expense of (₹39.77 lakh), the net profit for the quarter stood at ₹44.11 lakh.
Earnings Per Share
Basic and diluted earnings per equity share for the quarter were ₹1.43.
Financial Highlights (Half Year Ended September 30, 2026)
Income Statement
The total income for the half-year ended September 30, 2026, was ₹14,692.27 lakh, with total expenses at ₹14,529.40 lakh.
Profitability
Profit before tax for the half-year was ₹162.87 lakh. The net profit after a tax expense of ₹31.16 lakh was ₹131.71 lakh.
Earnings Per Share
Basic and diluted earnings per equity share for the half-year were ₹4.26.
Balance Sheet Summary (As at September 30, 2026)
Assets
Total Assets as of September 30, 2026, were ₹13,133.87 lakh, comprising non-current assets of ₹2,298.29 lakh and current assets of ₹10,835.58 lakh.
Equity and Liabilities
Total Equity stood at ₹6,949.63 lakh, with Total Liabilities at ₹6,136.91 lakh. The Total Equity and Liabilities matched the Total Assets.
Cash Flow Statement Summary (Half Year Ended September 30, 2026)
Operating Activities
Net cash used in operating activities was (₹477.03 lakh).
Investing Activities
Net cash generated from investing activities was (₹111.99 lakh).
Financing Activities
Net cash generated from financing activities was ₹600.41 lakh.
Cash Position
The net increase in cash and cash equivalents for the half-year was ₹11.39 lakh, bringing the cash and cash equivalents at the end of the year to ₹599.63 lakh.
Review Report
The accompanying statement of unaudited standalone financial results has been reviewed by Divyesh J Shah and Associates, Chartered Accountants. The auditors stated that nothing came to their attention that caused them to believe the statement was not prepared in accordance with applicable accounting standards and regulations, and that it disclosed all required information without material misstatement.
Source: BSE
